These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17991208)

  • 1. Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African-Americans.
    Agodoa L; Eggers P
    Semin Dial; 2007; 20(6):577-85. PubMed ID: 17991208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
    Ma L; Langefeld CD; Comeau ME; Bonomo JA; Rocco MV; Burkart JM; Divers J; Palmer ND; Hicks PJ; Bowden DW; Lea JP; Krisher JO; Clay MJ; Freedman BI
    Kidney Int; 2016 Aug; 90(2):389-395. PubMed ID: 27157696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in incidence, outcome, and quality of life for African-Americans on hemodialysis.
    Owen WF
    Blood Purif; 1996; 14(4):278-85. PubMed ID: 8873953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences.
    Bleyer AJ; Tell GS; Evans GW; Ettinger WH; Burkart JM
    Am J Kidney Dis; 1996 Jul; 28(1):72-81. PubMed ID: 8712225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
    Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
    Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and the paradox of racial differences in dialysis survival.
    Crews DC; Sozio SM; Liu Y; Coresh J; Powe NR
    J Am Soc Nephrol; 2011 Dec; 22(12):2279-86. PubMed ID: 22021717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year mortality rates in US children with end-stage renal disease.
    Chavers BM; Molony JT; Solid CA; Rheault MN; Collins AJ
    Am J Nephrol; 2015; 41(2):121-8. PubMed ID: 25766310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Advantage of African American Dialysis Patients with End-Stage Renal Disease Causes Related to APOL1.
    Lertdumrongluk P; Streja E; Rhee CM; Moradi H; Chang Y; Reddy U; Tantisattamo E; Kalantar-Zadeh K; Kopp JB
    Cardiorenal Med; 2019; 9(4):212-221. PubMed ID: 30995638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in survival between black and white patients with diabetic end-stage renal disease.
    Cowie CC; Port FK; Rust KF; Harris MI
    Diabetes Care; 1994 Jul; 17(7):681-7. PubMed ID: 7924777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons from chronic renal diseases in African Americans: treatment implications.
    Agodoa L
    Ethn Dis; 2003; 13(2 Suppl 2):S118-24. PubMed ID: 13677426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study.
    Yao X; Lei W; Shi N; Lin W; Du X; Zhang P; Chen J
    BMC Nephrol; 2020 Jul; 21(1):310. PubMed ID: 32727426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minority advantage in diabetic end-stage renal disease survival on hemodialysis: due to different proportions of diabetic type?
    Medina RA; Pugh JA; Monterrosa A; Cornell J
    Am J Kidney Dis; 1996 Aug; 28(2):226-34. PubMed ID: 8768918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial factors in the incidence and causation of end-stage renal disease (ESRD).
    Easterling RE
    Trans Am Soc Artif Intern Organs; 1977; 23():28-33. PubMed ID: 910346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community.
    Pugh JA; Medina RA; Cornell JC; Basu S
    Diabetes; 1995 Dec; 44(12):1375-80. PubMed ID: 7589841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial and Ethnic Disparities in Use of and Outcomes with Home Dialysis in the United States.
    Mehrotra R; Soohoo M; Rivara MB; Himmelfarb J; Cheung AK; Arah OA; Nissenson AR; Ravel V; Streja E; Kuttykrishnan S; Katz R; Molnar MZ; Kalantar-Zadeh K
    J Am Soc Nephrol; 2016 Jul; 27(7):2123-34. PubMed ID: 26657565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-stage renal disease in US minority groups.
    Feldman HI; Klag MJ; Chiapella AP; Whelton PK
    Am J Kidney Dis; 1992 May; 19(5):397-410. PubMed ID: 1585925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction.
    Newsome BB; McClellan WM; Allison JJ; Eggers PW; Chen SC; Collins AJ; Kiefe CI; Coffey CS; Warnock DG
    Am J Kidney Dis; 2008 Aug; 52(2):251-61. PubMed ID: 18468746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of end stage renal disease in African Americans with lupus nephritis.
    Franco C; Yoo W; Franco D; Xu Z
    Bull NYU Hosp Jt Dis; 2010; 68(4):251-6. PubMed ID: 21162701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.